Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes-Reference-Cited by-同舟云学术

Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes

Published:2014-09-27 Issue:2 Volume:94 Page:233-238
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Schwaab Juliana,Knut Marcin,Haferlach Claudia,Metzgeroth Georgia,Horny Hans-Peter,Chase Andrew,Tapper William,Score Joannah,Waghorn Katherine,Naumann Nicole,Jawhar Mohamad,Fabarius Alice,Hofmann Wolf-Karsten,Cross Nicholas C. P.,Reiter Andreas

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-014-2221-y.pdf

Reference16 articles.

1. Jones AV, Kreil S, Zoi K et al (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106:2162–2168

2. Verstovsek S, Mesa RA, Gotlib J et al (2012) A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. N Engl J Med 366:799–807

3. Reiter A, Walz C, Watmore A et al (2005) The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 65:2662–2667

4. Griesinger F, Hennig H, Hillmer F et al (2005) A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia. Genes Chromosome Cancer 44:329–333

5. Peeters P, Raynaud SD, Cools J et al (1997) Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535–2540

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage;Annals of Hematology;2024-02-03

2. Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects;Comprehensive Hematology and Stem Cell Research;2024

3. Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review;Genes;2023-12-08

4. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases;Histopathology;2023-08-08

5. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort;Leukemia;2023-07-15